KARRATIO
Live / Registered — Registered (as of 02 Jan 2024)
What this means for you
Registered since 02 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90890688
- Registration number
- 7257160
- Mark type
- Design + words
- Filed
- 18 Aug 2021
- Published for opposition
- 17 Oct 2023
- Registered
- 02 Jan 2024
- Attorney of record
- Jong Park
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cells, namely, chimeric antigen receptor T-cell (CAR-T), for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostral, murine, chimeric, humanized, human, monoclonal, and polyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells
- Class 042 — Scientific and technological services: Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Owner
- Eutilex Co., Ltd., Seoul, KR
- Eutilex Co., Ltd., Seoul, KR
- Eutilex Co., Ltd., Seoul, KR
Prosecution history
- 02 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Aug 2023 — ASSIGNED TO LIE
- 14 Apr 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 30 Mar 2023 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 30 Mar 2023 — INQUIRY TO SUSPENSION E-MAILED
- 30 Mar 2023 — SUSPENSION INQUIRY WRITTEN
- 30 Sept 2022 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 30 Sept 2022 — LETTER OF SUSPENSION E-MAILED